We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ITI Life Sciences and Cognia Signs Technology Licensing Agreement
News

ITI Life Sciences and Cognia Signs Technology Licensing Agreement

ITI Life Sciences and Cognia Signs Technology Licensing Agreement
News

ITI Life Sciences and Cognia Signs Technology Licensing Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ITI Life Sciences and Cognia Signs Technology Licensing Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ITI Life Sciences has announced the signing of a commercialisation licence with Cognia EU Ltd. The licence will enable Cognia to develop a new database product that will streamline researchers’ access to essential scientific information.

Initially the licence permits Cognia to build a single information database around a key subject of interest to drug discovery professionals. Both parties anticipate executing a permanent agreement later this year that will enable Cognia to construct human curated database.

Cognia, as a participant in the ITI Life Sciences Text Mining research programme, has the rights to license the intellectual property (IP) for Life Science applications.

The technology being licensed was developed as part of a three-year ITI Life Sciences R&D programme, involving the University of Edinburgh’s School of Informatics and Cognia, which began in March 2005.

ITI Life Sciences will receive royalties on sales of the product produced using this technology, which will be re-invested in this and other programmes. Financial terms were not disclosed.

Deputy First Minister Nicol Stephen said: “This latest announcement is excellent news for the Scottish economy. ITI Life Sciences’ fifth licence agreement further demonstrates the success of the three ITIs. The revenue generated from these licence agreements is invested straight back into the Scottish economy. It will help to stimulate growth and create new jobs, giving Scottish companies the opportunity to benefit from cutting edge technologies.

“This programme has also highlighted the high level of skills and knowledge in the workplace that is available to international companies locating in Scotland.”

Advertisement